These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25176938)

  • 21. Metabolic syndrome and incidence of type 2 diabetes in patients with manifest vascular disease.
    Wassink AM; Van Der Graaf Y; Soedamah-Muthu SS; Spiering W; Visseren FLj;
    Diab Vasc Dis Res; 2008 Jun; 5(2):114-22. PubMed ID: 18537099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risks for type-2 diabetes associated with the metabolic syndrome and the interaction between impaired fasting glucose and other components of metabolic syndrome the study from Jiangsu, China of 5 years follow-up.
    Liu SJ; Guo ZR; Hu XS; Wu M; Chen FM; Kang GD; Zhou H; Guo L
    Diabetes Res Clin Pract; 2008 Jul; 81(1):117-23. PubMed ID: 18485514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Waist circumference adds to the variance in plasma C-reactive protein levels in elderly patients with metabolic syndrome.
    Dupuy AM; Jaussent I; Lacroux A; Durant R; Cristol JP; Delcourt C
    Gerontology; 2007; 53(6):329-39. PubMed ID: 17551260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prevalence of metabolic syndrome in Chinese postmenopausal women and the optimum body composition indices to predict it.
    Ruan X; Jin J; Hua L; Liu Y; Wang J; Liu S
    Menopause; 2010; 17(3):566-70. PubMed ID: 20054286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
    Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
    Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans.
    Choi KM; Lee J; Lee KW; Seo JA; Oh JH; Kim SG; Kim NH; Choi DS; Baik SH
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):75-80. PubMed ID: 15212647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
    Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
    Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of weight and weight change on normalization of prediabetes and on persistence of normal glucose tolerance in an older population: the KORA S4/F4 study.
    Kowall B; Rathmann W; Heier M; Holle R; Peters A; Thorand B; Herder C; Strassburger K; Giani G; Meisinger C
    Int J Obes (Lond); 2012 Jun; 36(6):826-33. PubMed ID: 21863002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic syndrome and incidence of asthma in adults: the HUNT study.
    Brumpton BM; Camargo CA; Romundstad PR; Langhammer A; Chen Y; Mai XM
    Eur Respir J; 2013 Dec; 42(6):1495-502. PubMed ID: 23845717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum and dietary antioxidant status is associated with lower prevalence of the metabolic syndrome in a study in Shanghai, China.
    Li Y; Guo H; Wu M; Liu M
    Asia Pac J Clin Nutr; 2013; 22(1):60-8. PubMed ID: 23353612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of serum adipocyte fatty acid-binding protein on the development of metabolic syndrome is independent of pro-inflammatory cytokines.
    Park SE; Rhee EJ; Lee WY; Kim WJ; Yoo SH; Bae JC; Choi ES; Park CY; Oh KW; Park SW; Kim SW
    Nutr Metab Cardiovasc Dis; 2012 Jun; 22(6):525-32. PubMed ID: 21186114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of sex hormone-binding globulin and testosterone in the risk of incident metabolic syndrome.
    Haring R; Völzke H; Spielhagen C; Nauck M; Wallaschofski H
    Eur J Prev Cardiol; 2013 Dec; 20(6):1061-8. PubMed ID: 22711969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intake of fish and n-3 fatty acids and future risk of metabolic syndrome.
    Baik I; Abbott RD; Curb JD; Shin C
    J Am Diet Assoc; 2010 Jul; 110(7):1018-26. PubMed ID: 20630158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
    Fiuza M; Cortez-Dias N; Martins S; Belo A;
    Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic syndrome profiles, obesity measures and intake of dietary fatty acids in adults: Tehran Lipid and Glucose Study.
    Shab-Bidar S; Hosseini-Esfahani F; Mirmiran P; Hosseinpour-Niazi S; Azizi F
    J Hum Nutr Diet; 2014 Apr; 27 Suppl 2():98-108. PubMed ID: 23731333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Larger hip circumference independently contributed to reduced metabolic risks in Tehranian adult women.
    Esmaillzadeh A; Mirmiran P; Moeini SH; Azizi F
    Int J Cardiol; 2006 Apr; 108(3):338-45. PubMed ID: 15963581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistent high prevalence of cardiovascular risk factors in the urban middle class in India: Jaipur Heart Watch-5.
    Gupta R; Sharma KK; Gupta A; Agrawal A; Mohan I; Gupta VP; Khedar RS; Guptha S
    J Assoc Physicians India; 2012 Mar; 60():11-6. PubMed ID: 22799108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity and abdominal obesity; an alarming challenge for cardio-metabolic risk in Turkish adults.
    Oğuz A; Temizhan A; Abaci A; Kozan O; Erol C; Ongen Z; Celik S
    Anadolu Kardiyol Derg; 2008 Dec; 8(6):401-6. PubMed ID: 19103534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analytical characterization and clinical evaluation of an enzyme-linked immunosorbent assay for measurement of afamin in human plasma.
    Dieplinger B; Egger M; Gabriel C; Poelz W; Morandell E; Seeber B; Kronenberg F; Haltmayer M; Mueller T; Dieplinger H
    Clin Chim Acta; 2013 Oct; 425():236-41. PubMed ID: 23981841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacodynamic effects of rosiglitazone in nondiabetic patients with metabolic syndrome.
    Aquilante CL; Kosmiski LA; Zineh I; Rome LC; Knutsen SD
    Pharmacotherapy; 2010 Mar; 30(3):236-47. PubMed ID: 20180607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.